AG-236

N/A

Report date: 2025/07/22 20:00:10
NME

Base Information

Drug NameAG-236
Drug Alias NameAG-236
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTransmembrane protease serine 2 modulatorsRNA interference
TargetsTransmembrane protease serine 2
Therapy Area/IndicationsPolycythemia Vera
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAgios Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPolycythemia Vera
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A